CIRS Treatment Protocol: The Shoemaker Steps and Integrative Additions
A physician's roadmap to treating Chronic Inflammatory Response Syndrome—from CSM binding to VIP nasal spray—with integrative additions for refractory cases.
Infectiology
Emerging EvidenceChronic inflammatory response syndrome from biotoxin and mold exposure.
A physician's roadmap to treating Chronic Inflammatory Response Syndrome—from CSM binding to VIP nasal spray—with integrative additions for refractory cases.
Comparing mold testing methods — urine mycotoxin testing for body burden, ERMI for environmental exposure, and air sampling limitations. Which test you actually need.
How to distinguish CIRS from MCAS, why they frequently co-occur, and why treating only one often fails. HLA-DR genetics, mast cell activation, and the upstream driver.
The 37 symptoms of CIRS across 13 clusters, HLA-DR genetic susceptibility, and why 25% of the population cannot clear biotoxins normally.
Chronic Inflammatory Response Syndrome from mold exposure. How it overlaps with chronic infections, diagnosis, and treatment approaches.